US3284297A - 2-n-methylammoniumethylthiosulfuric acid and its use as a radioprotective agent - Google Patents

2-n-methylammoniumethylthiosulfuric acid and its use as a radioprotective agent Download PDF

Info

Publication number
US3284297A
US3284297A US161370A US16137061A US3284297A US 3284297 A US3284297 A US 3284297A US 161370 A US161370 A US 161370A US 16137061 A US16137061 A US 16137061A US 3284297 A US3284297 A US 3284297A
Authority
US
United States
Prior art keywords
acid
radiation
methylammoniumethylthiosulfuric
radioprotective
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US161370A
Other languages
English (en)
Inventor
Norman A Rosenthal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ATK Launch Systems LLC
Original Assignee
Thiokol Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thiokol Corp filed Critical Thiokol Corp
Priority to US161370A priority Critical patent/US3284297A/en
Priority to FR917943A priority patent/FR2500M/fr
Priority to GB47523/62A priority patent/GB964239A/en
Application granted granted Critical
Publication of US3284297A publication Critical patent/US3284297A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate

Definitions

  • This invention relates to radioprotective agents and more particularly, to a novel compound which is especially useful as a protective agent against the deleterious effects of ionizing radiation.
  • radioprotective agents are useful in a number of different fields. For example, in connection with the current space exploration program it is contemplated that various forms of animal life will be projected through areas of concentrated radiation wherein either external or internal protection will be required. It is evident that to the extent that chemical radioprotective agents are available, the external shielding provided in the space vehicle and hence its weight can be materially reduced. Therefore, the development of such radioprotective agents is important to the space program.
  • Radioprotective agents provide the radiotherapist with means for increasing the dosage tolerance of healthy tissue surrounding a diseased area, thereby making possible the use of higher and hence more effective radiation levels for treatment of the diseased tissue.
  • the 2-N-methylammoniumethylthiosulfuric acid which is believed to be a new compound, can be conveniently prepared by reaction of nitrogen mustard (N-methyl-betachloroeth-yl amine hydrochloride) with an alkali metal thiosulfate according to the following equation.
  • the product obtained is an internal salt of the organothiosulfuric acid, commonly known as a z-witterion. While the equation has been written in terms of sodium thiosulfate, other alkali metal thiosulfates can be used. In order to illustrate the mehod of preparation of this compound, two exemplary procedures which have been found satisfactory are given herein.
  • Example 1 A one-liter flask equipped with a reflux condenser, mechanical stirrer and heating mantle was charged with 0.55 mol (137 grams) of sodium thiosulfate pentahydrate and 137 grams of ethylene glycol solvent, and the mixture in the flask was heated and agitated until the thiosulfate dissolved. Thereafter, 0.5 mol (65 grams) of N-methyl-beta-chloroethylamine hydrochloride was added to the solution in the flask with continued heat and agitation. A 10% molar excess of the thiosulfate was used.
  • the reaction mixture was held at pH 6 and refluxed at a temperature ranging from to 113 C. for a period of 3.5 hours. Consumption of thiosulfate was followed by iodine titration of aliquots withdrawn from the reaction mixture at various time intervals. During the terminal portion of the reaction period, no further consumption of thiosulfate was noted.
  • a total net weight of 26 grams of crystalline methylammoniumethylthiosulfuri'c acid was obtained having a molecular weight by non-aqueous titration of 177 as compared with a theoretical M.W. of 171.
  • the yield of the product was 27.3% and its melting point 160 to 162 C.
  • Microchemical analysis showed that the product contained 20.96% carbon, 5.38% hydrogen, 8.25% nitrogen, and 37.16% sulfur as compared with a theoretical content of these elements of 21.20% C, 5.28% H, 8.20% N and 37.4% S. Ignition of a sample of the crystals over an open flame left no inorganic residue.
  • Example 2 Two reaction bombs were each charged with 0.74 mol (96 grams) of nitrogen mustard, 0.81 mol (129 grams-10% excess) of anhydrous sodium thiosulfate and 600 ml. of a mixture of equal volumes of ethanol and water. The bombs were placed in a 120 C. oven for four hours. The contents of the bombs were then combined and filtered. The filtrate was concentrated on a roto-dryer to remove most of the solvent, and then filtered hot to separate the salt precipitated during concentration.
  • Example 1 A quantity of 2-N-methylammoniumethylthiosulfuric acid as prepared in Example 1 was tested for toxicity and radioprotective activity.
  • toxicity tests adult male mice weighing between 20 and 25 grams were employed. Both the control and experimental animals were picked at random from the same lot in order that their age and weight would be comparable. Groups of five mice were injected intra-peritoneally with an aqueous saline solution at a pH of about 7. The quantity of the solution used in the toxicity tests (and also in the radiation tests) was somewhat less than 2% of the body weight of the animals. Dosage levels of 250 to 500 milligrams per kilogram of body weight were administered to different groups of animals and mortality was reported for a period of 10 days. It was found that no mortality occurred at dosages of 300 mg./kg., and this drug level was used as a maximum in the radiation tests.
  • mice were injected with a solution of the type described above. Drug levels of 300, 150, 75 and mg./kg. were administered to different groups of mice. The animals were then inserted in individual 50 ml. plastic centrifuge tubes which were placed radially on a rotating turntable so that each animal received an equal exposure of 800 roentgens of Whole body X-radiation.
  • the X-ray apparatus was operated at 250 kv., 15 ms.; the radiation was filtered by 0.25 mm. of copper and 1.0 mm. of aluminum; and the target-skin distance was 75 cm. Dose rate was 40 r. to 43 r. per minute.
  • the present invention provides a novel radioprotective compound that is markedly superior to various closely related chemical compounds.
  • Table I show that the monomethyl derivative of ammoniumthiosulfuric acid claimed herein is superior to the unsubstituted ammoniumethylthiosulfuric acid and is also superior to the dimethyl substituted ammoniumethylthiosulfuric acid.
  • the product of the present invention is substantially less toxic than for example the mercapto compounds previously proposed as radioprotective agents.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
US161370A 1961-12-22 1961-12-22 2-n-methylammoniumethylthiosulfuric acid and its use as a radioprotective agent Expired - Lifetime US3284297A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US161370A US3284297A (en) 1961-12-22 1961-12-22 2-n-methylammoniumethylthiosulfuric acid and its use as a radioprotective agent
FR917943A FR2500M (fr) 1961-12-22 1962-12-07 Composé anti-radiations.
GB47523/62A GB964239A (en) 1961-12-22 1962-12-17 A radioprotective thiosulphate-betaine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US161370A US3284297A (en) 1961-12-22 1961-12-22 2-n-methylammoniumethylthiosulfuric acid and its use as a radioprotective agent

Publications (1)

Publication Number Publication Date
US3284297A true US3284297A (en) 1966-11-08

Family

ID=22580916

Family Applications (1)

Application Number Title Priority Date Filing Date
US161370A Expired - Lifetime US3284297A (en) 1961-12-22 1961-12-22 2-n-methylammoniumethylthiosulfuric acid and its use as a radioprotective agent

Country Status (3)

Country Link
US (1) US3284297A (fr)
FR (1) FR2500M (fr)
GB (1) GB964239A (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100330733B1 (ko) * 1999-11-30 2002-04-03 노광 폴리에틸렌글리콜포스페이트, 그의 합성방법 및 그를방사능보호제로 사용하는 방법
JP2012046502A (ja) * 2010-07-28 2012-03-08 Sumitomo Chemical Co Ltd アミノアルキルチオ硫酸化合物の製造方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2236515A (en) * 1938-02-11 1941-04-01 Emulsol Corp Preparation of organic nitrogenous base salts
US2262720A (en) * 1940-06-21 1941-11-11 Clarence E Earle Medicinal composition
US2278123A (en) * 1939-01-17 1942-03-31 Heyn Myron Antispasmodics
US2647924A (en) * 1950-03-30 1953-08-04 Hoffmann La Roche 3-hydroxyphenyl quaternary ammonium compounds

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2236515A (en) * 1938-02-11 1941-04-01 Emulsol Corp Preparation of organic nitrogenous base salts
US2278123A (en) * 1939-01-17 1942-03-31 Heyn Myron Antispasmodics
US2262720A (en) * 1940-06-21 1941-11-11 Clarence E Earle Medicinal composition
US2647924A (en) * 1950-03-30 1953-08-04 Hoffmann La Roche 3-hydroxyphenyl quaternary ammonium compounds

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100330733B1 (ko) * 1999-11-30 2002-04-03 노광 폴리에틸렌글리콜포스페이트, 그의 합성방법 및 그를방사능보호제로 사용하는 방법
JP2012046502A (ja) * 2010-07-28 2012-03-08 Sumitomo Chemical Co Ltd アミノアルキルチオ硫酸化合物の製造方法

Also Published As

Publication number Publication date
FR2500M (fr) 1964-05-04
GB964239A (en) 1964-07-22

Similar Documents

Publication Publication Date Title
US3784582A (en) 1-amidino-3-(cyanophenyl)ureas
DE2845496A1 (de) N hoch 2 -substituierte phenyl-2,6- diaminonebularine und sie enthaltende arzneimittelzubereitungen
US3236871A (en) 3, 5-dinitro-o-toluhydroxamic acid and esters and anhydrides thereof
US3371014A (en) Method of combating angina pectoris and a pharmaceutical preparation suitable for this purpose
US3334126A (en) Aryl n-methyl substituted thionocarbamates
DE2359536A1 (de) 2,6-diaminonebularinderivate
DE3821317A1 (de) Thioharnstoffderivate
GB1585963A (en) Aryl sulphur compounds
US2918401A (en) Treatment of nematodes with quaternary ammonium compounds
US3846491A (en) Derivatives of n-2-hydroxyphenylthiourea
US3467705A (en) Neurotropic amides from n-substituted aminomethyl-nor-camphane and a procedure for their preparation
US2920074A (en) 1-(5-nitrofurfurylideneamino)-2-imidazolidinethione
CA2156700A1 (fr) Composes pharmaceutiques
US2637731A (en) Imidazopyridines
US3060206A (en) 2, 4-disulfamyl-5-alkoxy-aniline
US2724721A (en) Mercaptals of halogenated salicyaldehydes
US3079392A (en) Triazolo(4-3, b)pyridazines
US3855317A (en) 2-4-halobenzyl phenols and preparation thereof
US2426276A (en) Preparations active against cocci infections
NO143084B (no) Innretning for skallfjerning av marine krepsdyr, spesielt antarktisk krill.
US3423424A (en) 3-phenyl-4-dialkylaminoalkyl-pyrazol-5-ol compounds
US3366660A (en) Dibenzo cycloheptene thioiminoesters
KR970009042B1 (ko) 1,4,10,13-테트라옥사-7,16-디아자씨클로옥타데칸 유도체와 상기 유도체를 함유한 약제학적 조성물
US3761597A (en) 1-amidino-3-(substituted-phenyl) urea antimalarial composition and method of use
GB1565021A (en) Pharmaceutical compositions containing alkylamine deratives